Literature DB >> 3987780

Cardioversion with flecainide in patients with atrial fibrillation of recent onset.

J J Goy, R Maendly, M Grbic, L Finci, U Sigwart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3987780     DOI： 10.1007/bf00547059

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Conversion of chronic atrial fibrillation to sinus rhythm with combined propranolol and quinidine treatment.

Authors:  S Stern
Journal:  Am Heart J       Date:  1967-08       Impact factor: 4.749

2.  Verapamil in atrial fibrillation: The expected, the unexpected, and the unknown.

Authors:  J B Schwartz
Journal:  Am Heart J       Date:  1983-07       Impact factor: 4.749

3.  Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart.

Authors:  A B Hodess; W P Follansbee; J F Spear; E N Moore
Journal:  J Cardiovasc Pharmacol       Date:  1979 Jul-Aug       Impact factor: 3.105

4.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

5.  Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.

Authors:  K J Hellestrand; A W Nathan; R S Bexton; R A Spurrell; A J Camm
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

6.  Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion.

Authors:  P E Fenster; K A Comess; R Marsh; C Katzenberg; W D Hager
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

7.  Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.

Authors:  M Hodges; J M Haugland; G Granrud; G J Conard; R W Asinger; F L Mikell; J Krejci
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690

8.  The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.

Authors:  D A Deano; D Wu; R K Mautner; R H Sherman; A I Ehsani; K M Rosen
Journal:  Chest       Date:  1977-05       Impact factor: 9.410
  8 in total
  6 in total

Review 1.  Chaos in the genesis and maintenance of cardiac arrhythmias.

Authors:  Zhilin Qu
Journal:  Prog Biophys Mol Biol       Date:  2010-11-13       Impact factor: 3.667

2.  Nonlinear and Stochastic Dynamics in the Heart.

Authors:  Zhilin Qu; Gang Hu; Alan Garfinkel; James N Weiss
Journal:  Phys Rep       Date:  2014-10-10       Impact factor: 25.600

3.  Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass.

Authors:  T P Gavaghan; A M Koegh; R P Kelly; T J Campbell; C Thorburn; J J Morgan
Journal:  Br Heart J       Date:  1988-12

Review 4.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Authors:  Jordi Heijman; Vincent Algalarrondo; Niels Voigt; Jonathan Melka; Xander H T Wehrens; Dobromir Dobrev; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2015-12-23       Impact factor: 10.787

Review 5.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 6.  Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Authors:  Stanley Nattel; Philip T Sager; Jörg Hüser; Jordi Heijman; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.